Location History:
- Hellevoetsluis, NL (2012)
- Eindhoven, NL (2014)
- Echt, NL (2015 - 2018)
Company Filing History:
Years Active: 2012-2018
Title: Ilse De Lange: Innovator in Cell Modification Technologies
Introduction
Ilse De Lange is a prominent inventor based in Echt, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the area of cell modification. With a total of 5 patents to her name, her work has the potential to impact various applications in genetic engineering and synthetic biology.
Latest Patents
One of her latest patents is titled "Cell modification method using essential genes as markers and optionally recycling these." This invention relates to a method for modifying a host cell at a target locus. The method involves providing a host cell with at least two site-specific recombination sites and a nucleic acid with an essential function. By introducing a further nucleic acid at the target locus and carrying out recombination, the essential function can be rendered non-functional, thereby modifying the host cell. Another notable patent is for a "Host cell for the production of a compound of interest." This invention describes a recombinant host cell designed for producing specific compounds, along with methods for creating such host cells and the production of the compounds themselves.
Career Highlights
Ilse De Lange is currently associated with Dsm IP Assets B.V., where she continues to innovate and develop new technologies. Her work is characterized by a strong focus on practical applications of genetic modification techniques, which can lead to advancements in various industries, including pharmaceuticals and agriculture.
Collaborations
Throughout her career, Ilse has collaborated with notable colleagues such as Jan Metske Van Der Laan and Mark Cristiaan Stor. These partnerships have likely contributed to her success and the development of her innovative patents.
Conclusion
Ilse De Lange stands out as a key figure in the field of biotechnology, with her innovative patents paving the way for advancements in cell modification technologies. Her contributions are expected to have a lasting impact on the industry.